BNTC

MKT CAP:$327M

Benitec Biopharma Inc.

Market Cap

$327M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$12.70+$0.11 (+0.87%)

Apr 23, 2026

Company Details

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human condition...

CEO

Jerel A. Banks

IPO Date

Jun 24, 2014

Website

benitec.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$38M

EPS (Diluted)

-$1.05

Free Cash Flow

-$18M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q3 2026

May 13, 2026

PENDING

Q2 2026

Feb 12, 2026

$0EPS -$0.26

Q1 2026

Nov 14, 2025

$0EPS -$0.22

FY 2025

Sep 22, 2025

$0EPS -$1.05

Q3 2025

May 14, 2025

$0EPS -$0.24

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 22	$25.0K	$25.0K	-$5M
Q3 22	$48.0K	$48.0K	-$3M
Q4 22	$0	-$9.0K	-$5M
Q1 23	$0	-$102.0K	-$5M
Q2 23	$14.0K	$14.0K	-$6M
Q3 23	$54.0K	$54.0K	-$4M
Q4 23	$7.0K	-$77.0K	-$5M
Q1 24	$0	$106.0K	-$6M
Q2 24	$0	-$1.0K	-$7M
Q3 24	$0	-$90.0K	-$4M
Q4 24	$0	-$91.0K	-$6M
Q1 25	$0	-$91.0K	-$6M
Q2 25	$0	-$81.0K	-$9M
Q3 25	$0	-$106.0K	-$10M
Q1 26	$0	-$118.0K	-$10M
Q2 26	$0	-$120.0K	-$13M

Valuation

Quarter	P/S	P/E
Q2 22	3198.6x	—
Q3 22	919.6x	—
Q4 22	689.6x	—
Q1 23	475.8x	—
Q2 23	85.7x	—
Q3 23	338.7x	—
Q4 23	469.4x	—
Q1 24	417.5x	—
Q2 24	562.9x	—
Q3 24	11832.5x	—
Q4 24	—	—
Q1 25	—	—
Q2 25	—	—
Q3 25	—	—
Q1 26	—	—
Q2 26	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 22	-$3M	-$3M
Q3 22	-$3M	-$3M
Q4 22	-$5M	-$5M
Q1 23	-$4M	-$4M
Q2 23	-$6M	$0
Q3 23	-$4M	-$4M
Q4 23	-$4M	-$4M
Q1 24	-$5M	-$5M
Q2 24	-$5M	-$5M
Q3 24	-$6M	-$6M
Q4 24	-$3M	-$3M
Q1 25	-$5M	-$5M
Q2 25	-$8M	-$8M
Q3 25	-$3M	-$3M
Q1 26	-$3M	-$3M
Q2 26	-$4M	-$4M

Capital Expenditures

Quarter	CapEx
Q2 22	$0
Q3 22	$0
Q4 22	$12.8K
Q1 23	$0
Q2 23	$6M
Q3 23	$0
Q4 23	$993
Q1 24	$0
Q2 24	$2
Q3 24	$179.4K
Q4 24	$564
Q1 25	$0
Q2 25	$12.0K
Q3 25	$6.0K
Q1 26	$0
Q2 26	$11.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 22	+2400.0%	+49.1%
Q3 22	+4700.0%	-7.5%
Q4 22	-100.0%	+22.8%
Q1 23	—	-5.0%
Q2 23	-44.0%	+15.7%
Q3 23	+12.5%	+25.3%
Q4 23	—	-3.8%
Q1 24	—	+28.3%
Q2 24	-100.0%	+23.2%
Q3 24	-100.0%	-5.7%
Q4 24	-100.0%	+21.7%
Q1 25	—	-1.4%
Q2 25	—	+24.3%
Q3 25	—	+145.8%
Q1 26	—	+76.7%
Q2 26	—	+131.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 22	$239.0K	956.0%
Q3 22	$192.0K	400.0%
Q4 22	$0	—
Q1 23	$302.0K	—
Q2 23	$0	0.0%
Q3 23	$71.0K	131.5%
Q4 23	$0	0.0%
Q1 24	$91.0K	—
Q2 24	$0	—
Q3 24	$192.0K	—
Q4 24	$454.0K	—
Q1 25	$435.0K	—
Q2 25	$943.0K	—
Q3 25	$3M	—
Q1 26	$5M	—
Q2 26	$7M	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q2 22	$3M	$2M	—
Q3 22	$2M	$1M	—
Q4 22	$3M	$2M	—
Q1 23	$3M	—	$2M
Q2 23	$4M	$2M	—
Q3 23	$3M	$1M	—
Q4 23	$3M	—	$1M
Q1 24	$4M	$2M	—
Q2 24	$5M	$2M	—
Q3 24	$3M	—	$1M
Q4 24	$4M	—	$2M
Q1 25	$4M	—	$2M
Q2 25	$5M	—	$3M
Q3 25	$6M	—	$4M
Q1 26	$3M	—	$6M
Q2 26	$6M	—	$7M

Revenue Segments

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$9M	$0	$9M
Q4 22	$4M	$0	$4M
Q1 23	$17M	$0	$17M
Q2 23	$11M	$0	$11M
Q3 23	$7M	$0	$7M
Q4 23	$2M	$0	$2M
Q1 24	$26M	$0	$26M
Q2 24	$20M	$0	$20M
Q3 24	$14M	$0	$14M
Q4 24	$51M	$0	$51M
Q1 25	$68M	$0	$68M
Q2 25	$78M	$0	$78M
Q3 25	$104M	$0	$104M
Q4 25	$98M	$0	$98M
Q1 26	$94M	$0	$94M
Q2 26	$189M	$0	$189M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 22	2M	0.0%	+90.0%
Q3 22	2M	0.0%	+72.1%
Q4 22	2M	0.0%	+15.8%
Q1 23	3M	+32.8%	+32.8%
Q2 23	6M	+153.9%	+237.3%
Q3 23	2M	-74.6%	-14.4%
Q4 23	7M	+299.8%	+242.2%
Q1 24	9M	+31.1%	+237.8%
Q2 24	10M	+19.4%	+58.9%
Q3 24	10M	+1.6%	+535.8%
Q4 24	10M	-3.6%	+53.3%
Q1 25	11M	+5.5%	+23.4%
Q2 25	22M	+107.4%	+114.2%
Q3 25	39M	+74.9%	+268.8%
Q1 26	42M	+7.6%	+311.7%
Q2 26	46M	+10.7%	+331.9%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 22	$1.8K	14
Q3 22	$3.4K	14
Q4 22	$0	18
Q1 23	$0	18
Q2 23	$778	18
Q3 23	$3.0K	18
Q4 23	$389	18
Q1 24	$0	18
Q2 24	$0	18
Q3 24	$0	18
Q4 24	$0	16
Q1 25	$0	16
Q2 25	$0	16
Q3 25	$0	16
Q1 26	$0	19
Q2 26	$0	19

Revenue / Employee